{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:39:21Z","timestamp":1793417961506,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05763-6","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T16:36:38Z","timestamp":1735403798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Monitoring disease activity and treatment response in ankylosing spondylitis: a retrospective study of hematologic inflammatory markers"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9920-3670","authenticated-orcid":false,"given":"Oznur","family":"Sadioglu Cagdas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3022-493X","authenticated-orcid":false,"given":"Neslihan","family":"Gokcen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2167-4509","authenticated-orcid":false,"given":"Ayten","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3273-7969","authenticated-orcid":false,"given":"Ayse","family":"Cefle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"issue":"4","key":"5763_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4078\/jrd.2023.0041","volume":"30","author":"SH Kim","year":"2023","unstructured":"Kim SH, Lee SH (2023) Updates on ankylosing spondylitis: pathogenesis and therapeutic agents. J Rheum Dis 30(4):220\u2013233. https:\/\/doi.org\/10.4078\/jrd.2023.0041","journal-title":"J Rheum Dis"},{"issue":"3","key":"5763_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.18502\/jovr.v16i3.9440","volume":"16","author":"N Ebrahimiadib","year":"2021","unstructured":"Ebrahimiadib N, Berijani S, Ghahari M, Pahlaviani FG (2021) Ankylosing spondylitis. J Ophthalmic Vis Res 16(3):462\u2013469. https:\/\/doi.org\/10.18502\/jovr.v16i3.9440","journal-title":"J Ophthalmic Vis Res"},{"key":"5763_CR3","doi-asserted-by":"publisher","unstructured":"Coskun Benlidayi I (2023) Bone health in autoimmune inflammatory rheumatic diseases. In: Rezaei N (ed) Translational Immunology, Translational Autoimmunity. Elsevier Inc., Academic Press. https:\/\/doi.org\/10.1016\/b978-0-323-85831-1.00002-4","DOI":"10.1016\/b978-0-323-85831-1.00002-4"},{"issue":"10","key":"5763_CR4","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Haroon N, Borenstein D, Wang R, Biehl A et al (2019) 2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol 71(10):1599\u20131613. https:\/\/doi.org\/10.1002\/art.41042","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"5763_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landew\u00e9 RBM, Van den Bosch FE, Boteva B, Bremander A et al (2023) ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 82(1):19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5763_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMra2206346","volume":"388","author":"A Mantovani","year":"2023","unstructured":"Mantovani A, Garlanda C (2023) Humoral innate immunity and acute-phase proteins. N Engl J Med 388(5):439\u2013452. https:\/\/doi.org\/10.1056\/NEJMra2206346","journal-title":"N Engl J Med"},{"key":"5763_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s42358-020-0113-5","volume":"60","author":"MH Al-Osami","year":"2020","unstructured":"Al-Osami MH, Awadh NI, Khalid KB, Awadh AI (2020) Neutrophil\/lymphocyte and platelet\/lymphocyte ratios as potential markers of disease activity in patients with ankylosing spondylitis: A case-control study. Adv Rheumatol 60:13. https:\/\/doi.org\/10.1186\/s42358-020-0113-5","journal-title":"Adv Rheumatol"},{"key":"5763_CR8","doi-asserted-by":"publisher","unstructured":"Wu J, Yan L, Chai K (2021) Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis. J Clin Lab Anal 35(9). https:\/\/doi.org\/10.1002\/jcla.23964","DOI":"10.1002\/jcla.23964"},{"issue":"4","key":"5763_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3343\/alm.2019.39.4.345","volume":"39","author":"AY Gasparyan","year":"2019","unstructured":"Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD (2019) The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases. Ann Lab Med 39(4):345\u2013357. https:\/\/doi.org\/10.3343\/alm.2019.39.4.345","journal-title":"Ann Lab Med"},{"key":"5763_CR10","doi-asserted-by":"publisher","first-page":"760214","DOI":"10.3389\/fimmu.2021.760214","volume":"12","author":"T Liang","year":"2021","unstructured":"Liang T, Chen J, Xu G, Zhang Z, Xue J, Zeng H, Jiang J, Chen T, Qin Z, Li H et al (2021) Platelet-to-Lymphocyte Ratio as an Independent Factor Associated with the Severity of Ankylosing Spondylitis. Front Immunol 12:760214. https:\/\/doi.org\/10.3389\/fimmu.2021.760214","journal-title":"Front Immunol"},{"key":"5763_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/jcla.21768","volume":"29","author":"F G\u00f6kmen","year":"2015","unstructured":"G\u00f6kmen F, Akbal A, Re\u015forlu H, G\u00f6kmen E, G\u00fcven M, Aras AB, Erba\u011f G, K\u00f6m\u00fcrc\u00fc E, Akbal E, Co\u015far M (2015) Neutrophil-Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis. J Clin Lab Anal 29:294\u2013298. https:\/\/doi.org\/10.1002\/jcla.21768","journal-title":"J Clin Lab Anal"},{"key":"5763_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5606\/ArchRheumatol.2015.4837","volume":"30","author":"E Erkol Inal","year":"2015","unstructured":"Erkol Inal E, Sunar I, Saratas S, Ergoglu P, Inal S, Yener M (2015) May Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios Indicate Disease Activity in Ankylosing Spondylitis? Arch Rheumatol 30:130\u2013137. https:\/\/doi.org\/10.5606\/ArchRheumatol.2015.4837","journal-title":"Arch Rheumatol"},{"issue":"2","key":"5763_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2174\/1573397117666210921114431","volume":"18","author":"N Khorrampazhouh","year":"2022","unstructured":"Khorrampazhouh N, Omranzadeh A, Fazeli B, Zarifian A, Ghodsi A, Amirkhanlou F et al (2022) A systematic review and meta-analysis of clinical studies on ankylosing spondylitis and neutrophil to lymphocyte ratio. Curr Rheumatol Rev 18(2):160\u2013167. https:\/\/doi.org\/10.2174\/1573397117666210921114431","journal-title":"Curr Rheumatol Rev"},{"issue":"5","key":"5763_CR14","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/14397595.2019.1645373","volume":"30","author":"GG Song","year":"2020","unstructured":"Song GG, Lee YH (2020) Red cell distribution width, platelet-to-lymphocyte ratio, and mean platelet volume in ankylosing spondylitis and their correlations with inflammation: A meta-analysis. Mod Rheumatol 30(5):894\u2013899 Epub 2019 Aug 1. PMID: 31313609","journal-title":"Mod Rheumatol"},{"issue":"3","key":"5763_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/ph16030379","volume":"16","author":"DH Moon","year":"2023","unstructured":"Moon DH, Kim A, Song BW, Kim YK, Kim GT, Ahn EY, So MW, Lee SG (2023) High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis. Pharmaceuticals 16(3):379. https:\/\/doi.org\/10.3390\/ph16030379","journal-title":"Pharmaceuticals"},{"key":"5763_CR16","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s00421-021-04668-7","volume":"121","author":"D Walzik","year":"2021","unstructured":"Walzik D, Joisten N, Zacher J, Zimmer P (2021) Transferring clinically established immune inflammation markers into exercise physiology: Focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index. Eur J Appl Physiol 121:1803\u20131814. https:\/\/doi.org\/10.1007\/s00421-021-04668-7","journal-title":"Eur J Appl Physiol"},{"key":"5763_CR17","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.3390\/jcm9092760","volume":"9","author":"B Targo\u0144ska-St\u0119pniak","year":"2020","unstructured":"Targo\u0144ska-St\u0119pniak B, Zwolak R, Piotrowski M, Grzechnik K, Majdan M (2020) The Relationship between Hematological Markers of Systemic Inflammation (Neutrophil-To-Lymphocyte, Platelet-To-Lymphocyte, Lymphocyte-To-Monocyte Ratios) and Ultrasound Disease Activity Parameters in Patients with Rheumatoid Arthritis. J Clin Med 9:2760. https:\/\/doi.org\/10.3390\/jcm9092760","journal-title":"J Clin Med"},{"key":"5763_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1055\/a-1976-6069","volume":"44","author":"J Zacher","year":"2023","unstructured":"Zacher J, Wesemann F, Joisten N, Walzik D, Bloch W, Predel G (2023) Cellular Integrative Immune Markers in Elite Athletes. Int J Sports Med 44:298\u2013308. https:\/\/doi.org\/10.1055\/a-1976-6069","journal-title":"Int J Sports Med"},{"issue":"1","key":"5763_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.29271\/jcpsp.2024.01.68","volume":"34","author":"S Khan","year":"2024","unstructured":"Khan S, Yousaf MJ, Rashid A, Manzar A (2024) Comparison of Platelets-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Rheumatoid Arthritis and Ankylosing Spondylitis. J Coll Physicians Surg Pak 34(1):68\u201372. https:\/\/doi.org\/10.29271\/jcpsp.2024.01.68","journal-title":"J Coll Physicians Surg Pak"},{"key":"5763_CR20","doi-asserted-by":"publisher","unstructured":"Coskun BN, Oksuz MF, Ermurat S, Tufan AN, Orucoglu N, Dogan A, Dalkilic E, Pehlivan Y (2014) Neutrophil-lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor drugs for ankylosing spondylitis. Eur J Rheumatol 1:101\u2013105. https:\/\/doi.org\/10.5152\/eurjrheumatol.2014.034","DOI":"10.5152\/eurjrheumatol.2014.034"},{"key":"5763_CR21","doi-asserted-by":"publisher","unstructured":"Wang J, Su J, Yuan Y, Jin X, Shen B, Lu G (2021) The role of lymphocyte-monocyte ratio on axial spondyloarthritis diagnosis and sacroiliitis staging. BMC Musculoskelet Disord 22:86. https:\/\/doi.org\/10.1186\/s12891-021-03973-8","DOI":"10.1186\/s12891-021-03973-8"},{"issue":"2","key":"5763_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/art.42333","volume":"75","author":"R Sen","year":"2023","unstructured":"Sen R, Kim E, Napier RJ et al (2023) Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Biomarkers in Axial Spondyloarthritis: Observational Studies From the Program to Understand the Longterm Outcomes in Spondyloarthritis Registry. Arthritis Rheumatol 75(2):232\u2013241. https:\/\/doi.org\/10.1002\/art.42333","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"5763_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.63032\/UTGY3244","volume":"3","author":"FR Martins","year":"2024","unstructured":"Martins FR, Bernardes M, Sequeira G, Costa L, Carvalho PD (2024) Neutrophile to lymphocyte and platelet to lymphocyte ratios predict clinical response to bDMARD in na\u00efve spondylarthritis patients. Neutrophile to lymphocyte and platelet to lymphocyte ratios predict clinical response to bDMARD in na\u00efve spondylarthritis patients. ARP Rheumatol 3(1):18\u201328. https:\/\/doi.org\/10.63032\/UTGY3244","journal-title":"ARP Rheumatol"},{"key":"5763_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.4149\/bll_2015_142","volume":"116","author":"A Kucuk","year":"2015","unstructured":"Kucuk A, Uslu AU, Ugan Y, Bagcaci S, Karahan AY, Akarmut A, Sahin A, Kucuksen S (2015) Neutrophil-to-lymphocyte ratio is involved in the severity of ankylosing spondylitis. Bratisl Med J 116:722\u2013725. https:\/\/doi.org\/10.4149\/bll_2015_142","journal-title":"Bratisl Med J"},{"key":"5763_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5606\/archrheumatol.2016.5729","volume":"31","author":"I Boyraz","year":"2016","unstructured":"Boyraz I, Koc B, Cogalgil S (2016) Assessment of Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Ankylosing Spondylitis. Arch Rheumatol 31:199\u2013200. https:\/\/doi.org\/10.5606\/archrheumatol.2016.5729","journal-title":"Arch Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05763-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05763-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05763-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T06:38:17Z","timestamp":1737700697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05763-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["5763"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05763-6","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest regarding the publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"10"}}